Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
Retrieved on:
Thursday, October 19, 2023
CORAL, AstraZeneca, SVKM's NMIMS, TAP Pharmaceuticals, Rich, Catalyst (nonprofit organization), Notre Dame, Rare, Biotechnology, Takeda, Laboratory, Neuralstem, Inc., Diabetes, MBA, Catalyst Pharmaceuticals, Abbott Laboratories, Senior, Executive, University, Kellogg School, Metreleptin, Culture, Patient, Marketing, Bachelor of Science in Human Biology, Central nervous system, Management, Pharmaceutical industry, Science, Catalysis, Lipodystrophy
Mr. Daly is a seasoned pharmaceutical executive bringing more than three decades of experience to Catalyst.
Key Points:
- Mr. Daly is a seasoned pharmaceutical executive bringing more than three decades of experience to Catalyst.
- "Today's announcement paves the way for a seamless transition for the new CEO at Catalyst.
- "I am honored to serve as Catalyst's new CEO at such a pivotal point in the Company's evolution," said Richard J. Daly.
- Prior to his appointment at Catalyst, Mr. Daly served as President of CARsgen Therapeutics Corporation since January 2022.